Epic | Jotup

John Muir Health and Ambience Healthcare Launch End-to-End Epic EHR Integrations with Generative AI

Retrieved on:

Tuesday, November 14, 2023

SAN FRANCISCO, Nov. 14, 2023 /PRNewswire/ -- John Muir Health (JMH) and Ambience Healthcare announced a collaboration today, launching a generative AI platform that is fully integrated with Epic's electronic health record (EHR).

Key Points:

SAN FRANCISCO, Nov. 14, 2023 /PRNewswire/ -- John Muir Health (JMH) and Ambience Healthcare announced a collaboration today, launching a generative AI platform that is fully integrated with Epic's electronic health record (EHR).
John Muir Health is well respected as one of the most forward thinking, innovative health systems in the country.
Working closely with Ambience and our colleagues at Epic, we're already seeing the technology revolutionize the patient and clinician experience at John Muir Health."
Currently, full-time clinicians at JMH are leveraging Ambience to save an average of 1-2 hours per day on EHR documentation.

HKSTP's Biggest Ever Elevator Pitch Competition 2024 Hits Four World Cities to Bring Global Innovators to Hong Kong and Springboard to Mainland China and Asia Success

Retrieved on:

Tuesday, October 17, 2023

Startups battle for up to US$5 million in venture funding, US$240,000 in cash prizes, plus unrivalled partnership and funding opportunities

Key Points:

Hong Kong's leading startup pitch competition also offers a total of US$240,000 in cash prizes, unrivalled business matching and funding opportunities, plus the ideal springboard to huge market opportunities in Mainland China, across Asia and beyond.
HKSTP is partnering again with world-leading accelerator Plug and Play to help take EPiC on this major global expansion.
From January to March 2024, four regional EPiC semi-finals will be hosted in Silicon Valley, Stuttgart, Singapore and Hong Kong, culminating with the grand finale in Hong Kong on 26 April 2024.
The finale will take place on 26 April 2024 at the sky100 venue, International Commerce Centre, Hong Kong, recreating a genuine elevator pitch experience for all participants.

HKSTP’s Biggest Ever Elevator Pitch Competition 2024 Hits Four World Cities to Bring Global Innovators to Hong Kong and Springboard to Mainland China and Asia Success

Retrieved on:

Tuesday, October 17, 2023

Hong Kong's leading startup pitch competition also offers a total of US$240,000 in cash prizes, unrivalled business matching and funding opportunities, plus the ideal springboard to huge market opportunities in Mainland China, across Asia and beyond.

Key Points:

Hong Kong's leading startup pitch competition also offers a total of US$240,000 in cash prizes, unrivalled business matching and funding opportunities, plus the ideal springboard to huge market opportunities in Mainland China, across Asia and beyond.
HKSTP is partnering again with world-leading accelerator Plug and Play to help take EPiC on this major global expansion.
From January to March 2024, four regional EPiC semi-finals will be hosted in Silicon Valley, Stuttgart, Singapore and Hong Kong, culminating with the grand finale in Hong Kong in April 2024.
The finale will take place in April 2024 at the sky100 venue, International Commerce Centre, Hong Kong, recreating a genuine elevator pitch experience for all participants.

Epic Celebrates World Teachers’ Day Announcing 2023-2024 Cohort of Educator Ambassadors

Retrieved on:

Thursday, October 5, 2023

In celebration of World Teachers’ Day, the leading digital reading platform for kids, Epic , welcomes 250 educators to its Epic Educator Ambassador Program for the 2023-2024 school year.

Key Points:

In celebration of World Teachers’ Day, the leading digital reading platform for kids, Epic , welcomes 250 educators to its Epic Educator Ambassador Program for the 2023-2024 school year.
The sixth annual cohort of educators will serve as ambassadors to inspire a love of reading and learning in students, while also bolstering and sharing best practices across the teaching profession.
In addition to inspiring educators and students, Epic Educator Ambassadors will influence the future development of the product by providing their expertise and feedback through surveys, interviews and advisory groups.
With the feedback from Epic’s Educator Ambassadors in previous years, Epic is excited to unveil its latest offering, Epic School Plus—now available to schools and districts worldwide.

Adaptive Announces Launch of Epic Integration for clonoSEQ®

Retrieved on:

Wednesday, September 13, 2023

This integration will allow providers to order and review clonoSEQ minimal residual disease (MRD) testing results in Epic as they would for any test performed directly at the site of care.

Key Points:

This integration will allow providers to order and review clonoSEQ minimal residual disease (MRD) testing results in Epic as they would for any test performed directly at the site of care.
clonoSEQ is also available for use in other lymphoid cancers and specimen types as a CLIA-validated laboratory-developed test (LDT).
Integration with Epic EHR provides convenient access to clonoSEQ MRD results along with discrete data directly in patient records, enabling faster, more efficient decision-making for oncologists and equipping patients with real-time insights into their disease status.
Practices that wish to access clonoSEQ MRD testing directly via Epic should contact their Adaptive account representative or Adaptive’s Account Operations team at [email protected].

Rhapsody Names Sagnik Bhattacharya Chief Executive Officer

Retrieved on:

Wednesday, September 13, 2023

Rhapsody , a global leader in healthcare interoperability, today announced the appointment of Sagnik Bhattacharya as chief executive officer.

Key Points:

Rhapsody , a global leader in healthcare interoperability, today announced the appointment of Sagnik Bhattacharya as chief executive officer.
By delivering access to data, Rhapsody helps healthcare organizations break down silos, accelerate innovation, and improve patient care.
A robust, flexible interoperability layer serves as a critical foundation for healthcare’s continued transformation,” said Sagnik Bhattacharya.
The addition of Sagnik Bhattacharya comes on the heels of Rhapsody’s recent appointment of Jeff Chiumiento as chief financial officer.

Novari Health's Integration with Epic Improves Referral & Central Intake Systems

Retrieved on:

Tuesday, September 12, 2023

Novari's integration with eReferral and Hospital EHR systems enables end-to-end central intake models.

Key Points:

Novari's integration with eReferral and Hospital EHR systems enables end-to-end central intake models.
The software's unique ability to enable customized local workflows for clinical pathways and central intake processes have resulted in Novari being the leading referral management & central intake solution provider in Canada.
Referrals are then digitally received, triaged, and processed by specialized regional central intake staff using the Novari referral management technology.
Novari is the only system that can support complex regional workflows, integration with eReferral systems (e.g., OceanMD), fax referrals, and bidirectional integration with hospital EHR systems (e.g., Epic, Oracle Cerner, Meditech, etc.).

EQS-News: invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding

Retrieved on:

Tuesday, September 5, 2023

invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding

Key Points:

invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding
The issuer is solely responsible for the content of this announcement.
invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding
Multi-center trial of novel autologous cell therapy APN401 leveraging two GMP-compliant manufacturing sites has received regulatory approval and patient recruitment has started;
invIOs awarded up to 45% funding of trial costs by Austrian Research Promotion Agency (FFG) to support Phase 1b RP2D trial;
invIOs recently also awarded grant funding to advance novel CAR-T cell therapy INV451 against lung cancer with Medical University of Innsbruck.
PALINDROM is a multi-center trial taking place in Austria with two GMP-compliant manufacturing sites in Vienna and Linz.
As part of the Austrian Life Sciences Programme 2023 initiative, the Austrian Research Promotion Agency (FFG) has awarded invIOs funding to support the PALINDROM study.

invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding

Retrieved on:

Tuesday, September 5, 2023

VIENNA, Austria, Sept. 05, 2023 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, today announces that it has started patient recruitment for a Phase 1b trial of its novel autologous cell therapy, APN401, in patients with solid tumors, and has successfully secured grant funding.

Key Points:

VIENNA, Austria, Sept. 05, 2023 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, today announces that it has started patient recruitment for a Phase 1b trial of its novel autologous cell therapy, APN401, in patients with solid tumors, and has successfully secured grant funding.
PALINDROM is a multi-center trial taking place in Austria with two GMP-compliant manufacturing sites in Vienna and Linz.
As part of the Austrian Life Sciences Programme 2023 initiative, the Austrian Research Promotion Agency (FFG) has awarded invIOs funding to support the PALINDROM study.
“I am delighted that the Austrian government is supporting our latest clinical trial using the EPiC cell therapy platform to develop an innovative and potentially game-changing approach to treating solid tumors,” said Peter Llewellyn-Davies, CEO of invIOs.

CLOUD 10 STUDIOS ANNOUNCES THE LAUNCH OF CLOUD 10 ORIGINALS

Retrieved on:

Wednesday, August 30, 2023

DALLAS and LAS VEGAS, Aug. 30, 2023 /PRNewswire/ -- Cloud 10 Studios, led by feature-production veteran Tracey Dispensa, announces the launch of Cloud 10 Originals.

Key Points:

DALLAS and LAS VEGAS, Aug. 30, 2023 /PRNewswire/ -- Cloud 10 Studios, led by feature-production veteran Tracey Dispensa, announces the launch of Cloud 10 Originals.
"We are very excited to be at the point where we can self-fund the development of several Cloud 10 originals working with these industry legends.
Cloud 10 Studios plans to execute its content as high-quality 3D animation, using both a 3D animation pipeline and a real-time pipeline leveraging Fortnite creator's Epic!
"We've already been using Unreal Engine for 80% of our projects at Cloud 10 Studios.